News

January 7, 2021January 7, 2021

Methotrexate, Humira Seen to Alter Immune Cell Counts in JIA Children

News

Significant changes were found in the immune cell levels of children with juvenile idiopathic arthritis (JIA) following treatment with methotrexate and Humira (adalimumab), a study reports. These findings help ... Read more

December 17, 2020December 17, 2020

JIA Patients Show Differences That May Affect Future Disease Activity, Study Says

News

An analysis using machine learning identified distinct patient groups and disease activity trajectories among young patients in the U.K. with juvenile idiopathic arthritis (JIA). Its findings revealed that nearly a quarter ... Read more

December 10, 2020December 10, 2020

Genome Analysis Identifies New JIA-linked Genetic Variants, Targets

News

A large-scale genome analysis has identified five genetic variants newly associated with disease susceptibility in multiple subtypes of juvenile idiopathic arthritis (JIA). The analysis also revealed several genes potentially ... Read more

December 3, 2020December 3, 2020

Free Online Booklet ‘My JIA’ Serves as Guide for Children, Families, and Schools

News

U.K. charity Juvenile Arthritis Research has published an informational booklet called “My JIA,” a resource for children with juvenile idiopathic arthritis (JIA), their families, caregivers, and schools. The booklet, ... Read more

November 26, 2020November 26, 2020

New $100M Program Aims to Improve Diversity in Clinical Trials

News, syndicated

A new $100-million program aims to improve the diversity of participants in U.S. clinical trials with the ultimate goal of achieving better health outcomes and parity in care for underserved ... Read more

November 19, 2020November 19, 2020

Methotrexate Prefilled Syringe, RediTrex, Now Available in US for pJIA, Other Disorders

News

Cumberland Pharmaceuticals has announced the launch of RediTrex, a new line of methotrexate prefilled syringes for the treatment of polyarticular juvenile idiopathic arthritis (pJIA), active rheumatoid arthritis, and severe psoriasis in the ... Read more

November 12, 2020November 12, 2020

ACR Updates JIA Treatment Guidelines to Emphasize Disease-modifying Therapies

News

The American College of Rheumatology (ACR) has issued new guidelines for treating juvenile idiopathic arthritis (JIA) that emphasize the use of disease-modifying therapies that have recently become available. The ... Read more

November 5, 2020November 5, 2020

Epstein-Barr Increases JIA Disease Activity, Impairs Treatment Response, Study Finds

News

Previous Epstein-Barr virus (EBV) infection is associated with increased disease activity and impaired response to treatment in children with juvenile idiopathic arthritis (JIA), a recent study has found. The study, “The Impact ... Read more

October 29, 2020October 29, 2020

Timing of Arthritis Flares Linked to Eye Inflammation in JIA, Study Finds

News

Eye inflammation tends to occur around the same time as arthritis flares in children with juvenile idiopathic arthritis (JIA), a new study indicates. This finding suggests that JIA patients’ ... Read more

October 22, 2020October 22, 2020

Corticosteroids Injection Near Jaw May Lessen JIA Joint Inflammation

News

A localized injection of corticosteroids into the temporomandibular joints (TMJs) — the joints near the ears where the jawbone connects to the skull — may ease inflammation and help ... Read more